abrdn Life Sciences Investors
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.24
資產淨值: 20.00
成立日期: 08/05/1992
 
分析
市值分佈:
45.39%
大市值
18.77%
中市值
14.63%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:39) 總持有投資項目: 82  
0%
 
100%
     10大 (24.09%)
代號 名稱 佔比% ▼ 持有日期
CRBPCorbus Pharmaceuticals Holdings0.6031/08/2026
JAZZJazz Pharmaceuticals plc0.5931/07/2026
ASNDAscendis Pharma A/S0.5431/08/2026
RYTMRhythm Pharmaceuticals0.5231/08/2026
ALKSAlkermes plc0.5031/08/2026
RCKTRocket Pharmaceuticals0.4931/08/2026
MAZEMaze Therapeutics Inc0.4831/08/2026
ALNYAlnylam Pharmaceuticals0.4731/08/2026
PVLAPalvella Therapeutics Inc0.4631/08/2026
JBIOJade Biosciences Inc0.4531/08/2026
APMDApnimed Inc0.4231/08/2026
DFTXDefinium Therapeutics Inc0.3631/08/2026
NBIXNeurocrine Biosciences0.3631/08/2026
ELOXEloxx Pharmaceuticals Inc0.3131/08/2026
AVTXAvalo Therapeutics0.3031/08/2026
SPTXSeaport Therapeutics, Inc.0.1531/08/2026
KLRAKailera Therapeutics Inc0.1431/08/2026
SGPSpyGlass Pharma Inc0.1431/07/2026
EYPTEyePoint Inc.0.1231/08/2026
ODTXOdyssey Therapeutics, Inc.0.0531/08/2026
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.